AstraZeneca has halted it’s large-scale, later-stage global trial for a COVID-19 vaccine after a participant developed a severe adverse reaction. AstraZeneca will conduct a safety review to determine the link between the patient’s illness and the vaccine, the timeline of which is yet to be determined. AstraZeneca’s vaccine works through a modified chimpanzee adenovirus viral vector, which inserts coronavirus genes into human cells. This incident highlights the importance of clinical trials; as an integrated biopharmaceutical supply chain solutions provider offering a full range of primary and secondary packaging, logistics, storage and distribution services for the global pharmaceutical and biotech industries, Yourway is an ideal clinical trial partner globally.
6681 Snowdrift Road
Toll Free:
Fax:
Email:
